Journal Article

Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc

Quan Lili, Kusakizako Tsukasa, Wiriyasermkul Pattama, Nishizawa Tomohiro, Kanai Yoshikatsu, Jin Chunhuan, Shirouzu Mikako, Ohgaki Ryuichi, Okuda Suguru, Nureki Osamu, Lee, Yongchan, Oda Kazumasa, Ishitani Ryuichiro, Nakane Takanori, Yokoyama Takeshi, Nagamori Shushi, Endou Hitoshi

2019

Overview

The L-type amino acid transporter 1 (LAT1 or SLC7A5) transports large neutral amino acids across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a disulfide-linked heterodimer with CD98 heavy chain (CD98hc, 4F2hc or SLC3A2), but the mechanism of assembly and amino acid transport are poorly understood. Here we report the cryo-EM structure of the human LAT1–CD98hc heterodimer at 3.3-Å resolution. LAT1 features a canonical Leu T-fold and exhibits an unusual loop structure on transmembrane helix 6, creating an extended cavity that might accommodate bulky amino acids and drugs. CD98hc engages with LAT1 through the extracellular, transmembrane and putative cholesterol-mediated interactions. We also show that two anti-CD98 antibodies recognize distinct, multiple epitopes on CD98hc but not its glycans, explaining their robust reactivities. These results reveal the principles of glycoprotein-solute carrier assembly and provide templates for improving preclinical drugs and antibodies targeting LAT1 or CD98hc.Cryo-EM structure of the LAT1–CD98hc heterodimer in complex with two antibodies offers insights into the assembly and function of LAT1–CD98hc, and reveals the epitopes targeted by the potentially therapeutic antibodies with an antitumor activity.

• Publisher: Nature Publishing Group
• Subject: Amino acids / Antibodies / Assembly / Brain / Brain tumors / Cholesterol / Drug delivery / Drug delivery systems / Epitopes / Glycoproteins / Polysaccharides